US 9157121
Method of treatment based on polymorphisms of the KCNQ1 gene
granted A61KA61K31/454A61K31/496
Quick answer
US patent 9157121 (Method of treatment based on polymorphisms of the KCNQ1 gene) held by VANDA PHARMACEUTICALS INC. expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/454, A61K31/496, A61K31/519, A61P